Financial Reports

2024

2Q – 2024 Results

1Q – 2024 Results

2023

2023 Annual Report

2023 Form 10K

3Q – 2023 Results

2Q – 2023 Results

1Q – 2023 Results

2022

2022 Annual Report and Accounts (IFRS)

2022 Form 10K

3Q – 2022 Results

2Q – 2022 Results

2022 Semi-Annual Report (IFRS)

1Q – 2022 Results

2021

2021 Annual Report

2021 Form 10K

2021 Annual Report and Accounts (IFRS)

2021 Remuneration Report

3Q – 2021 Results

2Q – 2021 Results

2021 Semi-Annual Report (IFRS)

1Q – 2021 Results

2020

2020 Annual Report

2019

2019 Annual Report

2018

2018 Annual Report

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

This web site contains, and has materials that contain, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words ‘expected’, ‘will’, ‘may’, ‘should’ and similar expressions are intended to identify forward-looking statements.

Core Laboratories’ expectations regarding any specific matter is only its forecast regarding the matter. A forecast may be substantially different from actual results, which are affected by various factors that are either enumerated on each page or in the Company’s various filings with the Securities and Exchange Commission.